|
⚲
|
| Keyboard |
| Stengone Carmine N
✚
|
|
|---|---|
| CIK # | 0001861519 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001861519] | |
| 4 | [0001861519] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Stengone Carmine N | |
| Contineum Therapeutics Inc | |
| Kiora Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2026-02-25 | Option exercise | 2,700 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-25 | Sell | 2,700 | $16.02 | 43,254 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-25 | Option exercise | 2,700 | $1.26 | 3,402 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-24 | Option exercise | 4,400 | $1.26 | 5,544 |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2026-02-24 | Option exercise | 4,400 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-24 | Sell | 4,400 | $16.02 | 70,488 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-11 | Sell | 400 | $16.00 | 6,400 |
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2026-02-11 | Option exercise | 400 | $1.26 | 504 |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2026-02-11 | Option exercise | 400 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2026-01-30 | Grant | 445,000 | $0.00 | |
|
Kiora Pharmaceuticals Inc KPRX
Stock Option (right to buy) · derivative
|
2025-04-01 | Grant | 20,000 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2025-01-31 | Grant | 300,000 | $0.00 | |
|
Kiora Pharmaceuticals Inc KPRX
Common Stock
|
2024-09-11 | Buy | 1,250 | $3.68 | 4,600 |
|
Kiora Pharmaceuticals Inc KPRX
Stock Option (right to buy) · derivative
|
2024-07-01 | Grant | 1,778 | $0.00 | |
|
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
|
2024-05-24 | Grant | 285,000 | $0.00 | |
|
Kiora Pharmaceuticals Inc KPRX
Stock Option (right to buy) · derivative
|
2023-09-29 | Grant | 8,000 | $0.00 |